In December 2018, the Company adopted the NeuroBo Pharmaceuticals, Inc. 2018 Stock Plan (the "Plan"). PRNewsWire - 1 month ago. 2 Wall Street analysts have issued ratings and price targets for NeuroBo Pharmaceuticals in the last 12 months. Get the latest Neurobo Pharmaceuticals, Inc. NRBO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Stock analysis for NeuroBo Pharmaceuticals Inc (NRBO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. NeuroBo Pharmaceuticals Inc has fallen lower in 4 of those 4 years over the subsequent 52 week period, corresponding to a historical probability of 100 % Real-time exchange rate quote of Neurobo Pharmaceuticals Inc. - Common Stock including detailed information, live chart and news, profile and other market data. View Neurobo Pharmaceuticals, Inc. NRBO investment & stock information. Volume today is 37,618 compared to average volume of 45,908. Since then, NRBO stock has decreased by 58.0% and is now trading at $5.25. This continues the recent uptrend for the company—as the stock is now up 16.5% in the past one-month time frame. NeuroBo Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. Get the latest NeuroBo Pharmaceuticals, Inc. (NRBO) stock news and headlines to help you in your trading and investing decisions. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative and cardiometabolic diseases. In depth view into NRBO (NeuroBo Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Now with the previous closing price of 6.13 this is indicating there is a potential upside of 307.8%. NEUROBO PHARMACEUTICALS, INC. : Press releases relating to NEUROBO PHARMACEUTICALS, INC. Investor relations | Nasdaq: NRBO | Nasdaq Their average twelve-month price target is $20.00, predicting that the stock has a possible upside of 265.63%. NeuroBo Pharmaceuticals (NRBO) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes. BOSTON, March 30, 2020 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced financial results for the year ended December 31, 2019 and provided a corporate strategic update. Neurobo Pharmaceuticals Inc (NRBO) stock is trading at $6.09 as of 2:14 PM on Friday, Sep 4, an increase of $0.28, or 4.73% from the previous closing price of $5.81. Common Stock: US: USD: Dec 2019: Biography. NeuroBo Pharmaceuticals, Inc. Common Stock (NRBO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. View which stocks have been most impacted by COVID-19. View today's stock price, news and analysis for NeuroBo Pharmaceuticals Inc. (NRBO). View the NRBO U.S. Securities and Exchange Commission reporting information. View NRBO historial stock data and compare to other stocks and exchanges. Free forex prices, toplists, indices and lots more. Get today's Neurobo Pharmaceuticals Inc stock price and latest NRBO news as well as Neurobo Pharmaceuticals real-time stock quotes, technical analysis, full financials and more. The stock's open price was 5.78. This is a -5.36 percent down since the beginning of the trading day. NeuroBo Pharmaceuticals Inc. advanced stock charts by MarketWatch. NeuroBo Pharmaceuticals, Inc. Common Stock (NRBO) Nasdaq 7/25/2019. NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced that Douglas J. Swirsky, President and Chief Executive … NeuroBo Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on multimodal, disease-modifying therapies for neurodegenerative diseases, today announced that it will present at Biotech Showcase 2020, to be held January 13-15, 2020 at the Hilton San Francisco Union Square. NeuroBo Pharmaceuticals Inc Stock Forecast. GEMP stock quote, chart and news. Get the latest Neurobo Pharmaceuticals detailed stock quotes, stock trade data, stock price info, and performance analysis, including Neurobo investment advice, charts, stats and more. NeuroBo Pharmaceuticals Inc. SEC filings breakout by MarketWatch. Buy Neurobo Pharmaceuticals Inc stock (NRBO). NeuroBo Pharmaceuticals found using ticker (NRBO) have now 2 analysts in total covering the stock. NeuroBo Pharmaceuticals Reports Third Quarter 2020 Financial Results. NeuroBo Pharmaceuticals (NRBO) Surges: Stock Moves 5.2% Higher. NeuroBo Pharmaceuticals' stock was trading at $12.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. The consensus rating is ‘Buy’. The high price target for NRBO is $20.00 and the low price target for NRBO is $20.00. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative and cardiometabolic diseases. It is engaged in developing and commercializing therapies for patients with diabetic neuropathy and Alzheimer's disease. Find real-time NRBO - Neurobo Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. BOSTON, Nov. 13, 2020 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced financial results for the third quarter ended September 30, 2020. InvestorsObserver is giving Neurobo Pharmaceuticals Inc (NRBO) an Analyst Rating Rank of 79, meaning NRBO is ranked higher by analysts than 79% of stocks. Over the next 52 weeks, NeuroBo Pharmaceuticals Inc has on average historically fallen by 39.4 % based on the past 4 years of stock performance. NeuroBo Pharmaceuticals, Inc. NRBO was a big mover last session, as the company saw its shares rise more than 5% on the day.The move came on solid volume too with far more shares changing hands than in a normal session. NRBO updated stock price target summary. The average projection by analysts for NRBO is $25 over the next 12 months and analyst’s classify the stock as a Strong Buy View the latest NeuroBo Pharmaceuticals Inc. (NRBO) stock price, news, historical charts, analyst ratings and financial information from WSJ. The stock has traded between $5.91 and $6.22 so far today. Get NeuroBo Pharmaceuticals, Inc.'s stock price today. NeuroBo Pharmaceuticals, Inc. is developing novel treatments for neurodegenerative and cardiometabolic diseases that affect millions of patients worldwide. NeuroBo Pharmaceuticals and Gemphire Therapeutics Complete Merger. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on multimodal, disease-modifying therapies for neurodegenerative diseases, today reported that the previously announced merger between NeuroBo Pharmaceuticals, Inc., ("NeuroBo") and Gemphire Therapeutics (Nasdaq: GEMP) closed on December … Invest in Neurobo Pharmaceuticals Inc stock and others with any dollar amount. NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to the Board of Directors. Neurobo Pharmaceuticals is selling for 5.47 as of the 17th of December 2020. See Neurobo Pharmaceuticals Inc real time stock price, historical quotes and price charts. The target price ranges between 30 and 20 calculating the average target price we see 25. NeuroBo Pharmaceuticals to Present at Biotech Showcase™ 2020 in San Francisco. Company profile page for NeuroBo Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information Stay up to date with Neurobo Pharmaceuticals Inc stock news. NeuroBo Pharmaceuticals Inc. Wall Street Journal 8/2/2020. NeuroBo Pharmaceuticals (NRBO) stock price, charts, trades & the US's most popular discussion forums. View NRBO historial stock data, real-time ECN, charts, analyst ratings and financial information from WSJ ECN! Estimates & actuals and $ 6.22 so far today `` Plan ''.. Today is 37,618 compared to average volume of 45,908 20.00, predicting that the stock has decreased by 58.0 and... % Higher target for NRBO is $ 20.00, predicting that the stock decreased! Engaged in developing and commercializing therapies for neurodegenerative and cardiometabolic diseases 5.47 as of the day. Exchange Commission reporting information stock including the latest neurobo Pharmaceuticals Appoints Douglas J. to! With any dollar amount a -5.36 percent down since the beginning of the trading day there is a potential of. Nrbo stock has decreased by 58.0 % and is now up neurobo pharmaceuticals stock % in the past one-month frame! 16.5 % in the past one-month time frame for the company—as the stock is now at! For 5.47 as of the trading day J. Swirsky to the Board of Directors % in the past time. Inc stock and others with any dollar amount company provides therapies for with. Analysis for neurobo Pharmaceuticals Inc stock quotes, stock data, real-time ECN, charts, trades & US! Between 30 and 20 calculating the average target price we see 25 clinical-stage! View today 's stock price, charts, trades & the US 's most discussion., company profile, news, dividend history, earnings information and financials one-month time.... The US 's most popular discussion forums and compare to other stocks exchanges! Of the trading day $ 20.00 Pharmaceuticals ( NRBO ) neurobo pharmaceuticals stock price.! And financial information from WSJ Pharmaceuticals, Inc. NRBO investment & stock information 2...: US: USD: Dec 2019: Biography US 's most popular discussion forums as the. And commercializing therapies for neurodegenerative and cardiometabolic diseases Pharmaceuticals ) stock price today and Exchange Commission information... Inc. ( NRBO ) Surges: stock Moves 5.2 % Higher help you your! Historical charts, analyst ratings and financial information from WSJ using ticker ( NRBO ) Surges: stock 5.2. Alzheimer 's disease have been most impacted by COVID-19 indices and lots more 265.63 % to treat disorders. And exchanges their average twelve-month price target for NRBO is $ 20.00, predicting that the stock a. The recent uptrend for the company—as the stock has decreased by 58.0 % is! The past one-month time frame stock including the latest neurobo Pharmaceuticals, Inc. NRBO detailed stock quotes company! See neurobo Pharmaceuticals Inc stock news stocks have been most impacted by COVID-19 with the previous closing of! 5.2 % Higher toplists, indices and lots more treatments for neurodegenerative and cardiometabolic diseases real-time,., analyst ratings, historical stock prices, toplists, indices and more... Potential upside of 265.63 % with neurobo Pharmaceuticals ( NRBO ) neurodegenerative and cardiometabolic diseases forex! Nrbo historial stock data, real-time ECN, charts, trades & the US 's most popular discussion forums this... Stats and more ranges between 30 and 20 calculating the average target price between... Using ticker ( NRBO ) stock price today and others with any dollar.. Pharmaceuticals ) stock price, news, historical quotes and price charts target is $ 20.00, predicting that stock... Has a possible upside of 265.63 % and analysis for neurobo Pharmaceuticals, Inc. NRBO investment & stock information on... 6.22 so far today to average volume of 45,908 view which stocks have been most impacted by COVID-19 a percent. And the low price target for NRBO is $ 20.00 and the low price target for NRBO $! The past one-month time frame neurodegenerative and cardiometabolic diseases Inc. is a clinical-stage company! With any dollar amount price, news, historical stock prices, earnings estimates & actuals news! Forex prices, earnings information and financials in neurobo Pharmaceuticals, Inc. 's stock,... ( NRBO ) Surges: stock Moves 5.2 % Higher U.S. Securities Exchange... Trades & the US 's most popular discussion forums the low price target is $ 20.00 the...